Kyung NamWortman - Cellectis Ex Officer
| CMVLF Stock | USD 2.54 0.00 0.00% |
Insider
Kyung NamWortman is Ex Officer of Cellectis SA
| Age | 53 |
| Phone | 33 1 81 69 16 00 |
| Web | https://www.cellectis.com |
Cellectis Management Efficiency
The company has return on total asset (ROA) of (0.2408) % which means that it has lost $0.2408 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.557) %, meaning that it generated substantial loss on money invested by shareholders. Cellectis' management efficiency ratios could be used to measure how well Cellectis manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Joseph MPH | Mosaic Immunoengineering | 50 | |
| Simon Smith | Covalon Technologies | N/A | |
| Ron Hebert | Covalon Technologies | N/A | |
| Nicole Steinmetz | Mosaic Immunoengineering | 43 | |
| Greg Leszczynski | Covalon Technologies | N/A | |
| Mark Doolittle | Covalon Technologies | N/A | |
| Steven King | Mosaic Immunoengineering | 59 | |
| Jay Carlson | Mosaic Immunoengineering | N/A | |
| Gerry Arambula | Covalon Technologies | N/A | |
| Jason Gorel | Covalon Technologies | N/A | |
| Hamed Abbasian | Covalon Technologies | N/A | |
| Cyril Empig | Mosaic Immunoengineering | N/A | |
| Marvin MD | Mosaic Immunoengineering | 79 | |
| Elaine Zhang | Covalon Technologies | N/A | |
| Paul CPA | Mosaic Immunoengineering | 55 | |
Management Performance
| Return On Equity | -0.56 | |||
| Return On Asset | -0.24 |
Cellectis SA Leadership Team
Elected by the shareholders, the Cellectis' board of directors comprises two types of representatives: Cellectis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellectis. The board's role is to monitor Cellectis' management team and ensure that shareholders' interests are well served. Cellectis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellectis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andre Choulika, Chairman of the Board and CEO, Member of the Executive Committee | ||
| MarieBleuenn Terrier, General Counsel, Member of the Executive Committee | ||
| Dr MBA, Chief Officer | ||
| David Sourdive, Co-Founder, Executive VP of Corporate Devel. and Director | ||
| Valerie Cros, Principal Officer | ||
| Kyung NamWortman, Ex Officer | ||
| Philippe Duchateau, Chief Scientific Officer | ||
| Pascalyne Wilson, Director Communications | ||
| Jean Epinat, Chief Officer | ||
| MSc MSc, Chief Officer |
Cellectis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Cellectis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.56 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (6.01) % | |||
| Current Valuation | 82.79 M | |||
| Shares Outstanding | 55.59 M | |||
| Shares Owned By Institutions | 9.80 % | |||
| Price To Earning | (13.64) X | |||
| Price To Book | 0.79 X | |||
| Price To Sales | 4.79 X | |||
| Revenue | 57.29 M |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Cellectis Pink Sheet
When determining whether Cellectis SA is a strong investment it is important to analyze Cellectis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cellectis' future performance. For an informed investment choice regarding Cellectis Pink Sheet, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.